Albany Molecular Research, Inc. (AMRI) - Financial and Strategic SWOT Analysis Review

Date: February 2, 2016
Pages: 55
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A8DAE2168FBEN
Leaflet:

Download PDF Leaflet

Albany Molecular Research, Inc. (AMRI) - Financial and Strategic SWOT Analysis Review
Albany Molecular Research, Inc. (AMRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Albany Molecular Research, Inc. (AMRI) is a contract research and manufacturing organization. It offers integrated drug discovery, development and manufacturing services. Its services include drug discovery, such as discovery biology, medicinal chemistry, and in- vitro ADME; development, such as pre-formulation, formulation and validation; and manufacturing, such as cGMP API manufacturing; process scale up development and asceptic filling services for preclinical, clinical and commercial projects; and project management services. In addition to contracting services, the company also has a portfolio of seven proprietary drug discovery and development programs covering various therapeutic categories including infectious diseases, central nervous system disorders, metabolic disorders and oncology. The company has its presence in various locations across the US, Europe and Asia. AMRI is headquartered in Albany, New York, the US.

The company views acquisitions as an important part of its growth strategy to enhance or complement its existing service offerings. In lieu of this, in January 2015, the company acquired Aptuit's Glasgow, UK business.

Albany Molecular Research, Inc. Key Recent Developments

Jan 20, 2016: AMRI Announces Executive Hire to Lead Active Pharmaceutical Ingredients Business
Jan 12, 2016: AMRI Announces 3-Year Extension of Insourcing Contract
Nov 19, 2014: AMRI Announces Albuquerque, N.M. Manufacturing Facility Fully Operational
Nov 05, 2014: AMRI Announces Third Quarter 2014 Results
Sep 04, 2014: New Platforms Enhance AMRI's Discovery Biology Offerings

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

    Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
  • Note: Some sections may be missing if data is unavailable for the company
    SECTION 1 - ABOUT THE COMPANY

    Albany Molecular Research, Inc. - Key Facts
    Albany Molecular Research, Inc. - Key Employees
    Albany Molecular Research, Inc. - Key Employee Biographies
    Albany Molecular Research, Inc. - Key Operational Employees
    Albany Molecular Research, Inc. - Major Products and Services
    Albany Molecular Research, Inc. - History
    Albany Molecular Research, Inc. - Company Statement
    Albany Molecular Research, Inc. - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Albany Molecular Research, Inc. - Key Manufacturing Facilities

    SECTION 2 – COMPANY ANALYSIS

    Albany Molecular Research, Inc. - Business Description
    Albany Molecular Research, Inc. - Corporate Strategy
    Albany Molecular Research, Inc. - SWOT Analysis
    SWOT Analysis - Overview
    Albany Molecular Research, Inc. - Strengths
    Strength - Integrated Project Solution
    Strength - Focus on Licensing Agreements
    Strength - Increased Commercial Manufacturing Services
    Albany Molecular Research, Inc. - Weaknesses
    Weakness - Dependence on Small Group of Customers
    Weakness - Cost Control
    Weakness - Decline in Chemistry and Biology Services
    Albany Molecular Research, Inc. - Opportunities
    Opportunity - Strategic Alliances
    Opportunity - R&D Initiatives
    Opportunity - Inorganic Growth Strategies
    Albany Molecular Research, Inc. - Threats
    Threat - Intense Competition
    Threat - Uncertain R&D Outcomes
    Threat - Lengthy Drug Approval Process
    Albany Molecular Research, Inc. - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Albany Molecular Research, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Albany Molecular Research, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Albany Molecular Research, Inc., Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Jan 20, 2016: AMRI Announces Executive Hire to Lead Active Pharmaceutical Ingredients Business
    Jan 12, 2016: AMRI Announces 3-Year Extension of Insourcing Contract
    Dec 07, 2015: AMRI Launches its U.S. Integrated Drug Discovery Center
    Nov 05, 2015: AMRI Announces Third Quarter 2015 Results
    Sep 14, 2015: AMRI Promotes Two Company Executives to Key Positions
    Sep 03, 2015: AMRI Appoints Christopher Conway to Lead AMRI Global Discovery and Development Services Business; Names Vice President of Discovery Biology and Pharmacology
    Aug 31, 2015: Amri Announces Agreement With Saneca Pharmaceuticals, A.S. For Portfolio Of Opium-Derived Active Pharmaceutical Ingredients
    Aug 04, 2015: AMRI Announces Second Quarter 2015 Results
    Jun 17, 2015: AMRI and PerkinElmer Announce Drug Discovery Collaboration as part of the Buffalo Medical Innovation and Commercialization Hub
    Jun 17, 2015: AMRI and PerkinElmer Announce Drug Discovery Collaboration as part of the Buffalo Medical Innovation and Commercialization Hub

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Albany Molecular Research, Inc., Key Facts
    Albany Molecular Research, Inc., Key Employees
    Albany Molecular Research, Inc., Key Employee Biographies
    Albany Molecular Research, Inc., Key Operational Employees
    Albany Molecular Research, Inc., Major Products and Services
    Albany Molecular Research, Inc., History
    Albany Molecular Research, Inc., Subsidiaries
    Albany Molecular Research, Inc., Key Manufacturing Facilities
    Albany Molecular Research, Inc., Key Competitors
    Albany Molecular Research, Inc., Ratios based on current share price
    Albany Molecular Research, Inc., Annual Ratios
    Albany Molecular Research, Inc., Interim Ratios
    Albany Molecular Research, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Albany Molecular Research, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Albany Molecular Research, Inc., Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Albany Molecular Research, Inc., Performance Chart (2010 - 2014)
    Albany Molecular Research, Inc., Ratio Charts
    Albany Molecular Research, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Albany Molecular Research, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Albany Molecular Research, Inc. (AMRI) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: